Special Edition: Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)Diabetes Core UpdateWhat is the difference between MASH and MASLD? In this special episode, Dr. Neil Skolnik breaks down these conditions, which affect insulin resistance of the liver, an area of increasing concern for p...61 days agoSpecial Edition: Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)Diabetes Core Update0:00 / 0:00Read the original at diabetescoreupdate.libsyn.comUse this feed in your RSS readerCopy the publisher’s public feed URL, or build an OPML reading list for another reader.Copy RSS URL Open RSS feed · Find feeds & export OPMLKeep up with this sourceFollow this sourceKeep this source in your dashboard and return to its latest articles. Email alerts are managed separately in Settings.FetchFeeds groups articles by feed so you can follow sources, compare coverage, and save stories for later.Back to all articles from Diabetes Core UpdateMore from this feedChoose another story from Diabetes Core Update.Special Edition: Evidence-Based Strategies for Weight Loss and Long-Term Weight MaintenanceSpecial Edition: Evidence-Based Strategies for Weight Loss and Long-Term Weight Maintenance in People with DiabetesSpecial Edition: What's Next—The Role of Health Systems in Managing CKD Associated with T1D & T2DImpact of Finerenone on Albuminuria in T1D, National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs, and more!Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more!Special Edition: Hypertension Part I—Overview and ManagementSpecial Edition: Highlights from the ADA's 2026 Scientific SessionsSpecial Edition: Lp(a) & CV Risk